Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ApoCell for Prevention of Acute GvHD in HSCT
NCT00524784Phase 2Unknown
- Sponsor
- Hadassah Medical Organization
- Start
- Jun 2009
- Primary completion
- Dec 2012
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Allocetra in graft-versus-host disease (GVHD), sponsored by Hadassah Medical Organization. Status: unknown.
02
Drugs
Allocetra
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00524784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524784.